Analysis of the Development Strategies of the Export of Chinese Active Pharmaceutical Ingredients

Abstract

Objective To study the competitive advantages of Chinese active pharmaceutical ingredients by analyzing the international market situation and competition pattern of active pharmaceutical ingredient (API). Methods Through the analysis of the competition pattern of global API market, the advantages and shortcomings of China’s APIs in the international market were found out, and some development strategies and suggestions were put forward. Results and Conclusion It is urgent for China API enterprises to adjust their industrial structure, improve their production process, and actively participate in international certification for more export.

Keywords

API / export / development strategy

References

[1] Forward-Looking Industry Research Institute. Industry outlook - global and Chinese raw materials and pharmaceuticals industry analysis from 2023 to 2028 [EB/OL]. (2023-05-08)[2024-01-15]. https://baijiahao.baidu.com/s?id=1765312558764397957&wfr=spider&for=pc.

[2] Zhu Junsheng. Enhanced resistance to the “epidemic” of raw material drugs[N]. Journal of Pharmaceutical Economics, 2020-03-02 (007).

[3] Wang Di. High efficiency of raw material drugs to meet the production challenge[N]. Journal of Pharmaceutical Economics, 2019-09-09 (007).

[4] Zhu Renzong. The quantity of exports was thousands of tons, and the import growth rate was the highest in seven years[N]. China Medicine News, 2020-04-15 (004).

[5] Xu Ming. Rethinking the global positioning of China’s raw material pharmaceutical industry[N]. Journal of Pharmaceutical Economics, 2021-05-24 (F02).

[6] Wang Gaoling. SWOT analysis and strategic selection of China’s raw material pharmaceutical industry[J]. Shanghai Medicine, 2006 (10): 448-451.

[7] Lin Song, Qing Zhitao, Chen Hong. Development status and trend of APIs in China[J]. Process Industry, 2023 (8): 54-58+60-61.

[8] Wang Zhen. Obstacles and strategy selection of China’s raw material drug export[J]. Foreign Economic and Trade Practice, 2017 (4): 47-49.

[9] Zhang Xiong. Current situation and development of China’s API industry[J]. Fine and Specialty Chemicals, 2023, 31 (1): 6-8.

[10] Zhu Renzong. How to integrate the raw material pharmaceutical industry into the global market[N]. Journal of Pharmaceutical Economics, 2021-11-29 (001).

[11] Jing Wenna. Green transformation and industrial upgrading help China to become a strong country in raw material pharmaceutical production[N]. China Economic Review, 2021-11-11 (004).

[12] He Yufang, Zhang Chengye, Shen Kaiyue. Discussion on the development and upgrading strategy of chemical API industry in China under the background of high-quality development[J]. Applied Chemistry, 2023, 40 (3): 460-462.